Lana Ghanipour
Overview
Explore the profile of Lana Ghanipour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Enblad M, Cashin P, Ghanipour L, Graf W
Ann Surg Oncol
. 2025 Feb;
PMID: 39987383
No abstract available.
2.
Enblad M, Cashin P, Ghanipour L, Graf W
Ann Surg Oncol
. 2025 Jan;
PMID: 39841338
Background: Prediction of open-close and long-term outcome is challenging in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Prognostic scores often include factors not known at baseline. Therefore,...
3.
Fruhling P, Moberg L, Ghanipour L, Birgisson H, Graf W, Ericsson C, et al.
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001503
Appendiceal tumors are uncommon and, at times, discovered incidentally during histological examination. The histopathological classification of the disease is complex and has generated some controversy. The analysis of circulating tumor...
4.
Fruhling P, Moberg L, Ghanipour L, Birgisson H, Graf W, Ericsson C, et al.
Int J Surg
. 2024 Jul;
110(11):7187-7195.
PMID: 38978470
Background: The treatment for patients with colorectal cancer with metastases to the peritoneum is complex and may involve both surgery and chemotherapy. Circulating tumor cells (CTCs) have been poorly investigated...
5.
Enblad M, Birgisson H, Ghanipour L, Cashin P, Graf W
Int J Hyperthermia
. 2024 Jun;
41(1):2372356.
PMID: 38937059
Background: The greater omentum is routinely resected during cytoreductive surgery (CRS), but few studies have analyzed the rationale behind this. This study aimed to assess the prevalence of omental metastases...
6.
Cashin P, Asplund D, Bexe Lindskog E, Ghanipour L, Syk I, Graf W, et al.
Surg Open Sci
. 2024 Jun;
20:45-50.
PMID: 38911055
Background: Secondary treatment of recurrent colorectal peritoneal metastases after previous cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is poorly investigated. Objectives: To evaluate the overall survival outcome of secondary...
7.
Enblad M, Ghanipour L, Cashin P, Birgisson H, Graf W
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893218
Background: Careful macroscopic assessment of surgical scars is needed to avoid routine scar resection during cytoreductive surgery (CRS) for peritoneal metastases (PM). This study aimed to analyze the correlation between...
8.
Ghanipour L, Palmer G, Nilsson P, Nordenvall C, Frodin J, Bexe Lindskog E, et al.
PLoS One
. 2024 Mar;
19(3):e0294018.
PMID: 38437211
Standard treatment for patient with peritoneal metastases from colorectal cancer is cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). In recent years, the efficacy of oxaliplatin-based HIPEC has been challenged....
9.
Graf W, Ghanipour L, Birgisson H, Cashin P
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254775
Peritoneal metastases (PM) are observed in approximately 8% of patients diagnosed with colorectal cancer, either synchronously or metachronously during follow-up. PM often manifests as the sole site of metastasis. PM...
10.
Jansson Y, Graf W, Ghanipour L
World J Surg Oncol
. 2022 Sep;
20(1):300.
PMID: 36117176
Background: National lead time goals have been implemented across Sweden to standardize and improve cancer patient care. However, the prognostic impact of lead times has not yet been studied in...